[go: up one dir, main page]

WO1997012969A3 - Fmr1-related protein - Google Patents

Fmr1-related protein Download PDF

Info

Publication number
WO1997012969A3
WO1997012969A3 PCT/DE1996/001787 DE9601787W WO9712969A3 WO 1997012969 A3 WO1997012969 A3 WO 1997012969A3 DE 9601787 W DE9601787 W DE 9601787W WO 9712969 A3 WO9712969 A3 WO 9712969A3
Authority
WO
WIPO (PCT)
Prior art keywords
fmr1
protein
related protein
dna
codes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1996/001787
Other languages
German (de)
French (fr)
Other versions
WO1997012969A2 (en
Inventor
Annemarie Poustka
Johannes Coy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Priority to EP96945134A priority Critical patent/EP0851923A2/en
Priority to JP9513875A priority patent/JP2000500962A/en
Publication of WO1997012969A2 publication Critical patent/WO1997012969A2/en
Publication of WO1997012969A3 publication Critical patent/WO1997012969A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An FMR1-related protein is disclosed, as well as a DNA that codes for this protein, a process for preparing this protein, the use of this DNA and protein, and antibodies against this protein.
PCT/DE1996/001787 1995-09-19 1996-09-19 Fmr1-related protein Ceased WO1997012969A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP96945134A EP0851923A2 (en) 1995-09-19 1996-09-19 Fmr1-related protein
JP9513875A JP2000500962A (en) 1995-09-19 1996-09-19 FMR1-related protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1995134763 DE19534763C1 (en) 1995-09-19 1995-09-19 FMR1-related protein
DE19534763.3 1995-09-19

Publications (2)

Publication Number Publication Date
WO1997012969A2 WO1997012969A2 (en) 1997-04-10
WO1997012969A3 true WO1997012969A3 (en) 1997-07-17

Family

ID=7772586

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/001787 Ceased WO1997012969A2 (en) 1995-09-19 1996-09-19 Fmr1-related protein

Country Status (4)

Country Link
EP (1) EP0851923A2 (en)
JP (1) JP2000500962A (en)
DE (1) DE19534763C1 (en)
WO (1) WO1997012969A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000072201A (en) * 2000-08-17 2000-12-05 김희태 A method for diagnosing Fragile-X syndrome using DNA probes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038467A1 (en) * 1995-05-31 1996-12-05 The Trustees Of The University Of Pennsylvania Fragile x related proteins, compositions and methods of making and using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038467A1 (en) * 1995-05-31 1996-12-05 The Trustees Of The University Of Pennsylvania Fragile x related proteins, compositions and methods of making and using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SIOMI, M.C. ET AL.: "FRX1, an autosomal homolog of the fragile X mental retardation gene", EMBO JOURNAL, vol. 14, no. 11, 1 June 1995 (1995-06-01), EYNSHAM, OXFORD GB, pages 2401 - 2408, XP000673943 *
ZHANG, Y. ET AL.: "The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2", EMBO JOURNAL, vol. 14, no. 21, 1 November 1995 (1995-11-01), EYNSHAM, OXFORD GB, pages 5358 - 5366, XP000673942 *

Also Published As

Publication number Publication date
JP2000500962A (en) 2000-02-02
WO1997012969A2 (en) 1997-04-10
EP0851923A2 (en) 1998-07-08
DE19534763C1 (en) 1997-05-15

Similar Documents

Publication Publication Date Title
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
DE69534778D1 (en) Cathepsin-02-protease
AU7489596A (en) Reinforced formed part, process for its production and its use
AU5571396A (en) Process for preparing anti-obesity protein
HUP9602745A2 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
WO1996027665A3 (en) Neuron-restrictive silencer factor proteins
WO1995003328A3 (en) Melanoma-inhibiting protein
EP0831098A3 (en) Intermediates and process for preparing olanzapine
AU5678396A (en) Methods of preparing soluble, oligomeric proteins
AU7189496A (en) Catalysts for the oxichlorination of ethylene, method for preparing them, and oxichlorination method using the same
HUP9600325A3 (en) Dna sequence of a. thaliana, delta-7-red protein, process for producing thereof, yeats strains transformed by this dna and use thereof
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
WO1997035015A3 (en) Tyrosine-phosphatase-related protein
WO1997012969A3 (en) Fmr1-related protein
WO1997029194A3 (en) Preparation of l-ascorbic acid
CA2213742A1 (en) Process for preparing factor v-deficient plasma, and a deficient plasma which is obtained in this way
WO1997005253A3 (en) Transketolase-related protein
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.
ZA966661B (en) Catalyst, use thereof and preparation process.
AU5545896A (en) H. Influenzae HxuB and HxuC genes, proteins and methods of use
AU4716196A (en) Method of producing oxazolidinones, the use thereof and novel oxazolidinones
ATE309371T1 (en) PROTEIN WITH DNASE ACTIVITY
WO1998030687A3 (en) Protein containing an srcr domain
AU1693995A (en) Phosphacan, nucleic acids encoding thereof and antibodies thereto

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 513875

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996945134

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996945134

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996945134

Country of ref document: EP